Concepedia

Andrew D. Kelly

AD

15

Publications

651

Citations

12

H-Index

1996

Active since

Affiliations

Temple University(Current)

Harvard University

Beth Israel Deaconess Medical Center

Dana-Farber Cancer Institute

Massachusetts General Hospital

Andrew D. Kelly is an author at Temple University specializing in engineering, medicine, and radiation oncology.

ORCID

Top concepts

Publications per year

1996–2022

15

Publications

15

TET1-Mediated Hypomethylation Activates Oncogenic Signaling in Triple-Negative Breast Cancer

Charly R. Good, Shoghag Panjarian, Andrew D. Kelly et al. · Cancer Research · 2018 · 172 citations · Full text

MicroRNA paraffin-based studies in osteosarcoma reveal reproducible independent prognostic profiles at 14q32

Andrew D. Kelly, Benjamin Haibe‐Kains, Katherine A. Janeway et al. · Genome Medicine · 2013 · 116 citations · Full text

Metabolomic Profiling from Formalin-Fixed, Paraffin-Embedded Tumor Tissue Using Targeted LC/MS/MS: Application in Sarcoma

Andrew D. Kelly, Susanne B. Breitkopf, Min Yuan et al. · PLoS ONE · 2011 · 77 citations · Full text

, , +16

An imprinted non-coding genomic cluster at 14q32 defines clinically relevant molecular subtypes in osteosarcoma across multiple independent datasets

Katherine E. Hill, Andrew D. Kelly, Marieke L. Kuijjer et al. · Journal of Hematology & Oncology · 2017 · 42 citations · Full text

MicroRNA-155 expression is independently predictive of outcome in chordoma

Eiji Osaka, Andrew D. Kelly, Dimitrios Spentzos et al. · Oncotarget · 2015 · 40 citations · Full text

Rows per page

1–5 of 15